Items where Division is "03 Faculty of Medicine > Departement Public Health > Pharmazeutische Medizin ECPM"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Creators | Refereed
Jump to: 2022 | 2021 | 2020 | 2019 | 2018
Number of items at this level: 8.


Stoffel, Sandro T. and McGregor, Lesley and Hirst, Yasemin and Hanif, Sahida and Morris, Lorraine and von Wagner, Christian. (2022) Evaluation of the Call for a Kit intervention to increase bowel cancer screening uptake in Lancashire, England. Journal of Medical Screening, 29 (3). pp. 166-171.

Zgraggen, Armin and Stoffel, Sandro Tiziano and Barbier, Michaela Carla and Marbet, Urs Albert. (2022) Colorectal cancer surveillance by colonoscopy in a prospective, population-based long-term Swiss screening study - outcomes, adherence, and costs. Zeitschrift für Gastroenterologie, 60 (5). pp. 761-778.


Allan, Julia and Andelic, Nicole and Bender, Keith and Powell, Daniel and Stoffel, Sandro and Theodossiou, Ioannis. (2021) Employment contracts and stress: An experimental study. International Journal of Behavioral Medicine , 28 (1, Suppl.). S76.

Stoffel, Sandro and Coldwell, Ana Hvalica and von Wagner, Christian. (2021) Testing temporal frames of colorectal cancer risk: evidence from online experiments. International Journal of Behavioral Medicine, 28 (1, Suppl.). S104-S104.


Kaushal, Aradhna and Stoffel, Sandro Tiziano and Kerrison, Robert and von Wagner, Christian. (2020) Preferences for different diagnostic modalities to follow up abnormal colorectal cancer screening results: a hypothetical vignette study. BMJ Open, 10 (7). e035264.

Panje, C. M. and Lupatsch, J. E. and Barbier, M. and Pardo, E. and Lorez, M. and Dedes, K. J. and Aebersold, D. M. and Plasswilm, L. and Gautschi, O. and Schwenkglenks, M. and Swiss Group for Clinical Cancer Research, . (2020) A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland. Annals of Oncology, 31 (4). pp. 501-506.


Bhadhuri, Arjun and Insinga, Ralph and Guggisberg, Patrik and Panje, Cedric and Schwenkglenks, Matthias. (2019) Cost effectiveness of pembrolizumab vs chemotherapy as first-line treatment for metastatic NSCLC that expresses high levels of PD-L1 in Switzerland. Swiss Medical Weekly, 149 (51/52). w20170.


Bill, Marc and Mäder, Beatrice and Telser, Harry and Kaufmann, Cornel and Rieder, Stefan and Schwenkglenks, Matthias. (2018) Regulierungsfolgenabschätzung zur Einführung eines Referenzpreissystems in der Schweiz. Olten.

This list was generated on Fri Jul 12 03:46:21 2024 CEST.